CAS 543-82-8: (±)-1,5-Dimethylhexylamine

1,5-Dimethylhexylamine (1,5-DMHA) is a drug that is used as an analog for pentobarbital sodium. It has been shown to have anti-inflammatory effects in skin cells and can be used for the treatment of bowel disease. 1,5-DMHA has been found to inhibit the growth of Candida glabrata and other fungal species. This compound also prevents the initiation of inflammatory responses by suppressing the production of cytokines or chemokines in skin cells. 1,5-DMHA has not been evaluated in clinical trials because it is not approved by the US Food and Drug Administration or any other regulatory agency.

Octodrine (2-Amino-6-methylheptane) is primarily used as a pharmaceutical intermediate for Octamylamine; it also functions as a local anesthetic and vasoconstrictor.

Applications 1,5-Dimethylhexylamine is an aliphatic secondary amine which shows leucine aminotransferase inhibition. 1,5-Dimethylhexylamine is used in the preparation of glycosyl β-amino acids with antitubercular activity. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Raunio, R. et al.: Acta Chem. Scand., 27, 985 (1973); Tripathi, R.P. et al.: Eur. J. Med. Chem., 37, 773 (2002);